Drugs / XH-S002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06204419 | Dec 2023 → Jul 2024 | — | S-INFINITY Pharmaceuticals Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XH-S002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06204419 ↗ |
| Route | Oral | “administered orally” NCT06204419 ↗ |